Neuroglycopenic Seizures: Sulfonylureas, Sulfamethoxazole, or Both?

Am J Med. 2017 Jan;130(1):e29-e30. doi: 10.1016/j.amjmed.2016.08.011. Epub 2016 Sep 2.

Authors

Umer Khan¹, Santhosh Seetharaman², Reshma Merchant³

Affiliations

¹ Department of Medicine, National University Hospital, Singapore. Electronic address: umer_khan@nuhs.edu.sg.
² Geriatric Medicine, Department of Medicine, National University Hospital, Singapore.
³ Division of Advanced Internal Medicine, Geriatric Medicine, Department of Medicine, National University Hospital; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

PMID: 27593606
DOI: 10.1016/j.amjmed.2016.08.011

No abstract available

Publication types

Case Reports

MeSH terms

Aged, 80 and over
Diabetes Mellitus, Type 2 / diagnosis
Diabetes Mellitus, Type 2 / drug therapy*
Drug Interactions
Emergency Service, Hospital
Female
Follow-Up Studies
Frail Elderly
Humans
Hypoglycemia / chemically induced*
Hypoglycemia / complications
Hypoglycemia / physiopathology
Hypoglycemic Agents / adverse effects*
Hypoglycemic Agents / therapeutic use
Risk Assessment
Seizures / drug therapy
Seizures / etiology*
Seizures / physiopathology
Sulfamethoxazole / adverse effects*
Sulfamethoxazole / therapeutic use
Sulfonylurea Compounds / adverse effects*
Sulfonylurea Compounds / therapeutic use
Treatment Outcome

Substances

Hypoglycemic Agents
Sulfonylurea Compounds
Sulfamethoxazole